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Abstract 
Previously, we observed that the activity of the cysteine-specific lysosomal transport system increases 7-10-fold between pH 6 and 
7.3 to be maximally active in the neutral pH range. To understand what factors contribute to this pH dependence, different chemical 
modifying agents were used to probe the nature of amino acid residues residing in the transport protein binding site. Diethyl 
pyrocarbonate (1 mM) and N-ethylmaleimide (5 mM) each strongly inactivated lysosomal cysteine uptake > 88%, whereas dicyclohexyl- 
carbodiimide (2.5 mM), phenylisothiocyanate (2 mM), N-acetylimidazole (33 mM), and phenylglyoxal (2 mM) had a moderate to small 
effect. Maximal inactivation by DEPC occurs within 12-15 min upon exposure to DEPC concentrations > 1 mM. DEPC inactivation is
consistent with modification of a histidine residue, displaying no inactivation at pH < 6, half-maximal inactivation at pH 6.6, and 
maximal inactivation at pH > 7.3. The close correspondence of DEPC inactivation to the pH activity curve of cysteine uptake suggests 
the large increase in lysosomal cysteine transport activity between pH 6 and 7.3 reflects deprotonation f an essential histidine residue. 
The substrate, L-cysteine (4 mM), fully protects the transport protein from DEPC inactivation suggesting that this histidine residue is 
located in the carrier's ubstrate binding site. Finally, part of the pH dependence of the lysosomal cysteine carrier appears to be due to 
responsiveness to the lysosomal transmembrane proton gradient as indicated by lysosomal membrane vesicles which display a 1.5-fold 
greater ate of cysteine uptake when pH 7.4ou t > pH 5.3in than when pH 7.4ou t = pH 7.4in. 
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1. Introduction 
Lysosomes are a major intracellular site for the degrada- 
tion of a wide variety of macromolecules including pro- 
teins, complex carbohydrates, nucleic acids, and glycol- 
ipids. A large repertoire of hydrolytic enzymes undertake 
this task of degrading macromolecules within the lysoso- 
real compartment, yielding metabolites that are re-utilized 
for biosynthetic reactions in other cellular compartments. 
Recently, we described a cysteine-specific lysosomal trans- 
port system which displays high specificity for cysteine 
Abbreviations: DEPC, diethyl pyrocarbonate; Mops, 3-(N-morpho- 
lino)propanesulfonic a id; PBS, phosphate-buffered saline; DTT, dithio- 
threitol; Hepes, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; hex, 
/3-N-acetylhexosaminidase activity; Mes, 2-(N-morpholino)ethanesulfonic 
acid. 
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and is responsible for sequestering cysteine into the lysoso- 
mal compartment [1]. In this previous study, at least 
50-60% of the total radioactivity taken up by human 
fibroblasts during a 2-5 min incubation with 20 /zM 
L-[35S]cysteine was found to be sequestered into the lyso- 
somal compartment in the form of cysteine. This large 
percentage of cysteine accumulation into lysosomes is 
especially significant upon considering that lysosomes 
comprise only 4% of the intracellular volume of normal 
human fibroblasts [2]. The physiological importance of 
cysteine sequestration i to lysosomes by the cysteine- 
specific lysosomal transport route may be to aid lysosomal 
proteolysis by: (1) maintaining the catalytic activity of 
thiol-dependent lysosomal enzymes and (2) disrupting pro- 
tein disulfide bridges at susceptible linkages by 
sulfhydryl/disulfide exchange reactions, thereby allowing 
proteins to unfold, facilitating their degradation [1,3-5]. 
Since the description of this transport system, several 
studies have been published emonstrating the importance 
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of disulfide bond reduction and thiols in lysosomal func- 
tion. Barrueco et al. [6] recently showed that degradation 
of methotrexate polyglutamates within the lysosomal com- 
partment is highly dependent on the presence of reduced 
sulfhydryls and that cysteine ably fulfills this requirement. 
Collins, Unanue, and Harding [7] have demonstrated that 
reduction of disulfide bonds within lysosomes i a key step 
in antigen processing by macrophages suggesting that: (a) 
protein unfolding by reduction of disulfide bonds is a 
minimum processing requirement for at least some T cell 
epitopes, (b) disulfide bond reduction relaxes antigen struc- 
ture allowing lysosomal proteinases to gain access to more 
potential cleavage sites, thus enhancing proteolysis and 
thereby producing a larger variety of potentially immuno- 
genic peptides, and (c) T cell epitopes may contain cys- 
teine residues that are disulfide bonded within native anti- 
gens; recognition of these epitopes may require disulfide 
bond reduction to produce linear peptides in which the free 
thiol of cysteine residues is maintained in its reduced state. 
This latter possibility has been demonstrated by Jensen 
who showed that presentation of the major immunogenic 
epitope of insulin has an absolute requirement for disulfide 
bond reduction and that one likely site for this reduction is 
the lysosomal compartment [8]. 
Further investigation of the cysteine-specific lysosomal 
transport system may increase our understanding of the 
role which this transport system plays in maintaining thiol 
levels within the lysosomal compartment within various 
tissues, and in health and disease. Understanding the pH 
dependence of this carrier is key to understanding its 
ability to sequester cysteine into the lysosomal compart- 
ment. In this study, chemical modifying agents have been 
used to probe the nature of the amino acid residues re- 
quired for lysosomal cysteine transport as a means to 
understand the pH dependence of this carrier, and provide 
valuable information to guide future efforts in isolating the 
transport protein. 
2. Materials and methods 
2.1. Cell culture and preparation of percoll-purified lyso- 
somes 
Normal human fetal skin fibroblast cell lines (GM0010) 
were obtained from the Human Genetic and Mutant Cell 
Repository. Fibroblasts were grown and maintained in an 
atmosphere of 95% air/5% CO 2 in 100 mm tissue culture 
dishes or 850 cm 2 roller bottles in Coon's modification of 
Ham's F-12 medium (Sigma) supplemented with 10% fetal 
bovine serum. Confluent human fibroblast monolayers were 
routinely split 1:4 when passed using a CTC mixture 
consisting of 0.09% trypsin, 0.025% collagenase (Sigma, 
type IV,570 units/mg), and 2.2% heat-inactivated chicken 
serum in Ca 2+-, Mg2+-free Hank's salt solution, pH 7.6 
containing 2 mM Na2EDTA [9]. Fibroblasts were not used 
beyond passage 19. Fibroblast lysosomes were purified on 
a 31.7% Percoll density gradient as described previously 
[10], and generally were resuspended in 0.25 M sucrose or 
as indicated. Typically, four to six confluent roller bottles 
of fibroblasts were required to provide a sufficient quantity 
of lysosomes for accurate measurement of lysosomal cys- 
teine uptake. 
2.2. Chemical modification studies 
Percoll-purified lysosomes were suspended in different 
buffers for different ime intervals depending on the chem- 
ical modifying agent used. These conditions were: 0.25 
mM-2.0 mM diethyl pyrocarbonate (DEPC) in 50 mM 
potassium phosphate pH 7.3 buffer containing 0.25 M 
sucrose for 30 min at 30 ° C, or with 5 mM N-ethylmalei- 
mide in 40 mM Mops/Tris pH 7.4 buffer containing 0.25 
M sucrose for 35 rain at 30 ° C, or with 2.5 mM dicyclo- 
hexylcarbodiimide in 50 mM potassium phosphate pH 7.3 
buffer containing 0.25 M sucrose for 40 min at 30 ° C, or 
with 2 mM phenylglyoxal in 40 mM Mops/Tris pH 7.0 
buffer containing 0.25 M sucrose for 30 rain at 30 ° C, or 
with 2 mM phenylisothiocyanate in 40 mM Mops/Tris pH 
7.0 buffer containing 0.25 M sucrose for 30 min at 25 ° C, 
or 33 mM N-acetylimidazole in 50 mM potassium phos- 
phate pH 7.3 buffer containing 0.25 M sucrose for 40 min 
at 30 ° C. The above incubations were generally performed 
in a final volume of 0.15-0.2 mi and then terminated by 
diluting to 1.5 ml with wash buffer (20 mM Mops/Tris 
pH 7.0 buffer containing 0.275 M mannitol) followed by 
centrifugation for 15 min in an Eppendorf microcentrifuge 
at 15600 x g at 4 ° C. The supernatant was discarded, 
lysosomal pellets were washed once more with 1.5 ml of 
ice-cold wash buffer, centrifuged as above. The final pellet 
was gently resuspended by up and down pipetting in 
60-80 /xl of ice-cold 40 mM Mops/Tris pH 7.0 buffer 
containing 0.25 M sucrose immediately before the 5 min 
cysteine uptake time-course assay. An exception to the 
above washing procedure is that 10 mM imidazole was 
included in the first wash for terminating DEPC incuba- 
tions. 
2.3. Five minute cysteine uptake time-course assay with 
isolated lysosomes 
Lysosomes (30-60 /zl) in 40 mM Mops/Tris pH 7.0 
buffer containing 0.25 M sucrose were incubated at 37 ° C 
with 30-50 /zl of 30-40 /~M L-[3SS]cysteine in 20 mM 
Mops/Tris pH 7.0 buffer containing 0.25 M sucrose and 2 
mM dithiothreitol. Aliquots of equal volume were removed 
from the incubation mixtures at time points of 0.5', 1.5', 
2.5', 3.5', and 5'. These aliquots were mixed with 12 ml of 
ice-cold phosphate-buffered saline (PBS) and the lyso- 
somes were collected by filtration through a 24 mm GF/A  
glass fiber filter (Whatman). The filters were washed twice 
with 12 ml portions of ice-cold PBS, mixed with 16 ml of 
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Cytoscint (ICN), vortexed, and counted for radioactivity. 
Blanks were prepared by substituting suspension buffer for 
lysosomes in the above incubation mixtures. Radioactivity 
for the blanks was subtracted from the radioactivity ob- 
tained for the lysosome-containing samples. Time-courses 
were linear for the first .4-5 min of cysteine uptake. The 
initial rate of cysteine upl;ake for each incubation condition 
then was determined by linear regression analysis of the 
data using the Kaleidagraph software program (Synergy 
Software) and the data is expressed as pmol of L-cysteine 
taken up per min per /xg of lysosomal protein or per unit 
of /3-hexosaminidase activity. 
The L-[35S]cysteine uptakes performed to assess the pH 
dependence of lysosomal cysteine uptake did not involve a 
5 min time-course assay but rather uptakes were performed 
in duplicate for a 3.5 min incubation period at each 
indicated pH value. 
2.4. 1.-[35S]Cysteine upi'ake using lysosomal membrane 
vesicles 
Percoll-purified lysosomes, obtained from 6-8 roller 
bottles of human fibroblasts, were hypotonically l sed by 
suspending the lysosomal pellet in 3.0 ml of 10 mM 
Mops/Tris pH 7.6 buffer containing 1mM MgSO 4, 1 mM 
DTT, 25 /xg/ml pepstatin, and 5 /xg/ml of leupeptin, 
antipain, and aprotinin. The suspension was up and down 
pipetted five times, allowed to stand on ice for 15 min, 
mixed again, then centrifuged at 48 000 × g for 30 min at 
4 ° C in a Sorvall SS-34 rotor. The lysosomal membrane 
pellet was resuspended in 0.1-0.2 ml of either 20 mM 
Mops/Tris pH 7.4 buffer or 20 mM Mes/Tris pH 5.3 
buffer, resulting in the spontaneous formation of lysosomal 
membrane vesicles. L-[35S]Cysteine uptakes were per- 
formed by mixing lysosomal membrane vesicle suspension 
with the radioactive substrate at 37°C as described in the 
figure legends. Uptakes at a given time point were termi- 
nated by placing an aliquot from the incubation mixture 
onto a cold Sephadex (3-50 column (0.8 X 7.0 cm, in a 
KONTES Disposaflex column) equilibrated with 20 mM 
Na-Hepes pH 7.4 buffer at 4 ° C. Columns were washed 
with 1.5 ml of ice-cold column buffer; the eluant from this 
wash was collected irectly into scintillation vials, mixed 
with 16 ml of Cytoscint, and counted for radioactivity in a 
Beckman LS-100 scintillation counter. This chromatog- 
raphy method allows lysosomal membrane vesicles to be 
separated from extravesicular radioactivity ielding low 
background radioactivity as described by Mancini et al. 
[11]. 
2.5. ~-N-Acetylhexosaminidase andprotein assay 
The integrity of individual ysosomal preparations was 
generally found to be 80-90% intact as judged by the 
latency of fl-N-acetylhexosarninidase activity, which was 
calculated as the difference in hexosaminidase activity in 
the presence or absence of 0.1% Triton. /3-N-Acetylhe- 
xosaminidase activity (hex) was determined as described 
previously [12]. 
Lysosomal protein was quantified using bicinchoninic 
acid as described in the precipitation assay of Brown et al. 
[131. 
2.6. Miscellaneous 
L-[35S]Cystine (400-500 Ci/mmol, 1 mCi/ml) was 
obtained from Dupont/NEN and was purified either as 
described previously by chromatography on Dowex 50W- 
X8 cation exchange resin (1) and/or by high voltage 
electrophoresis. High voltage electrophoresis was per- 
formed by streaking 0.1-0.2 ml of concentrated radioac- 
tive material onto the origin of electrophoresis paper im- 
mediately followed by electrophoresis for 25 rain at 3500 
V in 6% formic acid using a CAMAG high voltage 
electrophoresis apparatus [14]. Cystine standards bordering 
the radioactive material were visualized by separately 
spraying these lanes of the electrophoretogram with a 
ninhydrin spray. Using the standards as markers, the ra- 
dioactive cystine lane was then cut out, eluted from the 
paper with deionized H20, concentrated under nitrogen 
gas, filtered through a 0.22 /zm Spin-X filter (Costar), 
stored at - 20 ° C, and used within 3 weeks of purification. 
L-[ 35 S]Cysteine was prepared from the purified [35 S]cystine 
by the addition of DTT as indicated in the various experi- 
ments. Percoll was purchased from Pharmacia LKB Bio- 
technology, N-ethylmaleimide was from Calbiochem- 
Behring; diethyl pyrocarbonate, dicyclohexylcarbodiimide, 
phenylglyoxal, phenylisothiocyanate, N-acetylimidazole, 
imidazole, and hydroxylamine were obtained from Sigma. 
3. Results 
The interest for the present investigation stemmed from 
our previous observation that the activity of the cysteine- 
specific lysosomal transport system increases 7-10-fold 
between pH 6 and 7.3 to be maximally active in the neutral 
pH range (Fig. 1). If this pH dependence of the cysteine- 
specific lysosomal transport system exists on both sides of 
the lysosomal membrane, then once cysteine is transported 
into lysosomes from the cytosol, the acidic intralysosomal 
pH would not be favorable for exodus of cysteine from 
lysosomes thereby resulting in net lysosomal cysteine ac- 
cumulation. The question we have addressed in the present 
investigation is what factors contribute to the pH depen- 
dence of the cysteine-specific lysosomal transport system. 
This pH dependence could be due to titration of amino 
acid residues of the transport protein essential for transport 
activity or also could reflect a dependence of the trans- 
porter on a transmembrane proton gradient. The best can- 
didate amino acid side chains, titratable in this pH range, 
are the imidazole group of a histidine residue or the 
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Fig. 1. pH dependence of 0.0131 mM L-[35S]cysteine uptake by human 
fibroblast lysosomes. Fibroblast lysosomes (12 /1.1) suspended in 0.25 M 
sucrose were incubated with 24 /zl of 0.0196 mM L-[35S]cysteine in 
either 15 mM Mes or 15 mM Mops buffers containing 0.25 M sucrose 
and 1 mM DTT and which had been titrated to the indicated pH with 
Tris-free base. Incubations were performed at 37 ° C for 3.5 min at which 
time 28 /~1 aliquots were removed from incubation mixtures, lysosomes 
were collected and washed on GF /A  filters, and the filters were mixed 
with 16 ml of Cytoscint for measurement of radioactivity. 
carboxyl side chain of an aspartyl or glutamyl residue 
residing in a hydrophobic pocket of the transport protein. 
In order to probe the nature of some of the amino acid 
residues required for transport activity of the cysteine- 
specific lysosomal transport system, we tested the ability 
of a variety of chemical modifying agents to inactivate 
lysosomal cysteine uptake in the neutral pH range. The 
results shown in Table 1 indicate that 1 mM diethyl 
pyrocarbonate (DEPC) and 5 mM N-ethylmaleimide were 
Table 1 
Inactivation of the cysteine-specific lysosomal transport system by vari- 
ous chemical modifying agents 
Transport activity 
(% of untreated control) 
N-Ethylmaleimide (5 mM) 4 
Diethyl pyrocarbonate (1 mM) 12 
Dicyclohexylcarbodiimide (2.5 mM) 99 
Phenylglyoxal (2 raM) 93 
Phenylisothiocyanate (2 mM) 85 
N-Acetylimidazole (33 mM) 78 
Human fibroblast lysosomes were incubated for 30-40 min at 30 ° C with 
the indicated chemical modifying agent in an isotonic buffer containing 
0.25 M sucrose at a pH of 7.0-7.5 depending on the chemical modifying 
agent as indicated in Materials and methods. Lysosomes then were 
centrifuged in ice-cold wash buffer, the pellets were re-suspended in
ice-cold wash buffer and re-centrifuged at 15600× g. The final lysoso- 
mal pellets were resuspended in 40 mM Mops/Tris pH 7.0 buffer 
containing 0.25 M sucrose and assayed for cysteine uptake in a 5 min 
time-course assay. Results are expressed as a percent of untreated con- 
trois which were carried through the same procedure but were not 
exposed to chemical modifying agents. Linear regression analysis was 
performed for each time-course with correlation coefficients ranging from 
r = 0.95 to 0.999. 
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Fig. 2. Concentration dependence of DEPC inactivation of lysosomal 
cysteine uptake. Lysosomes were incubated with the indicated concentra- 
tion of DEPC for 30 min at 30 ° C in 50 mM potassium phosphate pH 7.3 
buffer containing 0.25 M sucrose. Lysosomes were washed by 
dilution/centrifugation as described in Materials and methods, and the 
resultant pellets were resuspended in 75/xl of ice-cold 40 mM Mops/Tris 
pH 7.0 buffer containing 0.25 M sucrose. The rate of L-[35S]cysteine 
uptake for each lysosomal suspension then was measured by incubating 
60 pA aliquots of a given lysosomal suspension with 40 /zl of 3 l p.M 
L-[ 35 S]cysteine and performing a 5 min time-course assay as described in 
Materials and methods. Linear regression analysis was performed for 
each time-course assay with correlation coefficients ranging from r = 0.95 
to 0.999. Data are expressed as a percent of two controls not exposed to 
DEPC (ave. = 0.082 + 0.008 pmol L-cysteine taken up per min per /zg 
lysosomal protein). 
each able to strongly inactivate lysosomal cysteine uptake 
by 88-96%. DEPC has been shown to react with histidine 
residues or exposed a-amino groups, although some reac- 
tivity with thiols, serine, and tyrosine has been reported 
[ 15-18]. The strong inactivation caused by N-ethylmalei- 
mide suggests that a thiol may be important for the func- 
tion of this transport system. Because NEM could react 
with the radiolabelled substrate in these experiments, care 
was taken to wash NEM-treated lysosomes extensively so 
that residual NEM levels would be low enough that reac- 
tion with the L-[aSS]cysteine substrate used in the time- 
course assay would be negligible. The other chemical 
modifying agents that were tested, (1) dicyclohexylcarbo- 
diimide (reactive with carboxyl groups), (2) phenylisothio- 
cyanate (reactive with amino groups), (3) N-acetylimida- 
zole (reactive with tyrosine residues), and (4) phenylgly- 
oxal (reactive with arginine residues), had a moderate to 
very little effect on lysosomal cysteine transport activity. 
Further investigation of DEPC inactivation of lysosomal 
cysteine transport revealed that maximal inactivation oc- 
curs with DEPC concentrations > 1 mM (Fig. 2). DEPC 
inactivation of cysteine transport activity occurs rapidly 
with most of the inactivation occurring within the first 3 
min of exposure to DEPC and maximal evels of inactiva- 
tion being achieved after a 15 min exposure period (Fig. 
3). Maximal inactivation consistently resulted in an 85- 
90% loss of lysosomal cysteine transport activity. The 
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Fig. 3. Inactivation of lysosomal cysteine uptake by 1 mM DEPC as a 
function of time. Lysosomes were incubated for the indicated amount of 
time with 1 mM DEPC at 30 ° C in 50 mM potassium phosphate pH 7.3 
buffer containing 0.25 M sucrose. Lysosomes were washed by 
dilution/centrifugation as described in Materials and methods, and the 
resultant pellets were resuspended in 75/zl of ice-cold 40 mM Mops/Tris 
pH 7.0 buffer containing 0.25 M sucrose. The rate of L-[35S]cysteine 
uptake for each lysosomal suspension then was measured by incubating 
60 /zl aliquots of a given lysosomal suspension with 40 /zl of 31 /xM 
L-[3-~S]cysteine and performing a 5 min time-course assay as described in 
Materials and methods. Linear regression analysis was performed for 
each time-course assay with conelation coefficients ranging from r = 0.96 
to 0.999. Data are expressed as a percent of two controls not exposed to 
DEPC (ave. = 0.042 + 0.002 pmol L-cysteine taken up per min per /zg 
lysosomal protein). 
formation of this product (Ae = 3.0. 10 3 cm-1 M-  l) [15]. 
Using this as a spectrophotometric assay to quantitate 
[DEPC], cysteine was found not to diminish DEPC's reac- 
tivity with imidazole throughout a 20 min incubation at 
30°C in a 50 mM potassium phosphate pH 7.3 buffer 
containing 0.25 M sucrose (data not shown). These results 
indicate that cysteine does not react with DEPC under 
these reaction conditions. Therefore, in the substrate pro- 
tection experiment described above, protection by cysteine 
is not due to cysteine reacting with DEPC but indicates 
that occupation of the carrier's substrate binding site by 
cysteine protects essential amino acid residues of the car- 
tier protein from DEPC modification. Evidence for the 
specificity of protection was substantiated in a separate 
experiment (Table 2), demonstrating that L-alanine, which 
is not recognized by the cysteine-specific lysosomal trans- 
port system (1), does not protect his transport route from 
inactivation by 1 mM DEPC. It may be noteworthy to 
mention that the cysteine uptakes shown in Fig. 4 and 
Table 2 indicate that a greater rate of L-[35S]cysteine 
uptake was observed for those incubation mixtures in 
which L-cysteine was present in the pre-incubations at 
30°C as compared to the control in which cysteine was 
absent. This result may be an indication that a trans-stimu- 
lation property is associated with this transport system 
such that when lysosomes are pre-loaded with unlabelled 
cysteine, a greater ate of L-[35S]cysteine uptake is ob- 
served subsequently. 
10-15% of lysosomal cysteine uptake that remains follow- 
ing DEPC inactivation may be due to: (1) an ability of 
fibroblast lysosomes to transport cysteine by a minor, 
alternate route that is not sensitive to DEPC inactivation, 
(2) failure to achieve or maintain 100% modification of a 
transport protein amino acid residue essential for transport 
activity, or (3) an ability of the cartier to transport cysteine 
at a low transport rate ,despite DEPC modification. The 
present studies have not been able to distinguish among 
these possibilities. 
The substrate, L-cysteine, was assayed for its ability to 
protect he transport protein from inactivation by DEPC. In 
these studies, lysosomes were incubated with 1 mM DEPC 
at 30°C and pH 7.3 in tile presence or absence of 10 mM 
L-cysteine. Lysosomes then were diluted into an ice-cold 
wash buffer containing 10 mM imidazole to inactivate any 
residual DEPC, pelleted by centrifugation, washed once 
more in wash buffer without imidazole, and resuspended 
for the measurement of t,-[35S]cysteine uptake. The results 
shown in Fig. 4 demonstrate hat 10 mM L-cysteine was 
able to completely protect he transport protein from inacti- 
vation suggesting that the reactive amino acid essential for 
cysteine transport activity is located in the carrier's sub- 
strate binding site. DEPC is known to react with imidazole 
to form N-carbethoxyirrtidazole which can be monitored 
by the increase in UV absorbance at 230 nm due to the 
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Fig. 4. Ability of 10 mM L-cysteine to protect the cysteine-specific 
lysosomal transport system from inactivation by 1 mM DEPC at pH 7.3. 
Lysosomes were incubated at 30°C for 30 min in 50 mM potassium 
phosphate/0.25 M sucrose pH 7.3 buffer containing either 1 mM DEPC 
(A), 1 mM DEPC plus 10 mM L-cysteine (0) ,  10 mM L-cysteine (©), 
or no further addition (untreated control (zx)). Lysosomes were washed 
by dilution/centrifugation as described in Materials and methods, and the 
resultant pellets were resuspended to 65 ~1 with ice-cold 40 mM 
Mops/Tris pH 7.0 buffer containing 0.25 M sucrose. The rate of 
L-[35Slcysteine uptake for each lysosomal suspension then was measured 
by incubating 50 /xl aliquots of a given lysosomal suspension with 30 p.1 
of 30 tzM L-[35S]cysteine and performing a 5 min time-course assay as 
described in Materials and methods. 
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Table 2 
Comparison of the ability of 4 mM t.-alanine and 4 mM L-cysteine to 
protect he cysteine-specific lysosomal transport system from inactivation 
by 1 mM DEPC at pH 7.4 
Incubation condition Cysteine transport activity 
(pmol//xg protein) 
Buffer only (untreated control) 
Buffer+ l mM DEPC 
4 mM L-cysteine 
4 mM L-cysteine + 1 mM DEPC 
4 mM L-alanine 
4 mM L-alanine + 1 mM DEPC 
0.020 + 0.0005 
0.0001 + 0.00001 
0.0248 _+ 0.0008 
0.0245 _+ 0.0006 
0.0229 _+ 0.0011 
0.0006 + 0.00001 
Lysosomes were incubated at 30 ° C for 30 min in 50 mM potassium 
phosphate/0.25 M sucrose pH 7.3 buffer containing either: (i) 4 mM 
L-AIa, (ii) 4 mM t-Ala+ 1 mM DEPC, (iii) 4 mM L-cysteine, (iv) 4 mM 
t-cysteine + 1 mM DEPC, (v) 1 mM DEPC, or (vi) no further addition 
(untreated control). Lysosomes were washed twice by dilution/centrif- 
ugation as described in Materials and methods, and the resultant pellets 
were resuspended to 50 /xl with ice-cold 40 mM Mops/Tris pH 7.0 
buffer containing 0.25 M sucrose. The rate of L-[35S]cysteine uptake for 
each lysosomal suspension then was measured by incubating 10 /zl 
aliquots of a given lysosomal suspension with 6/xl of 30/zM L-[35S]cys- 
teine for 4 min at 37 ° C. At the end of the uptake period, 12 /zl aliquots 
were removed from the incubation mixtures and passed through a 
Sephadex G-50 column as described in Materials and methods. Material 
eluting in the void volume peak was collected and counted for radioactiv- 
ity. The results given below are an average of quadruplicate determina- 
tions and the standard error associated with these measurements. 
activity. No significant reactivation of cysteine transport 
activity was observed for DEPC-treated lysosomes that 
were subsequently incubated with hydroxylamine (Data 
not shown). In addition, controls which were not treated 
with DEPC showed a 40% loss in cysteine transport 
activity when exposed to 50 mM hydroxylamine atpH 7.3 
for 30 rain at 30 ° C. Mancini et al. have noted a similar 
effect of hydroxylamine in chemical modification studies 
of the lysosomal sialic acid carrier [19]. 
Even though the preceding data suggest that titration of 
a histidine residue in the transport protein binding site may 
be responsible for the pH dependence of the cysteine- 
specific lysosomal transport system, it does not exclude the 
possibility that the large increase in lysosomal transport 
activity between pH 6.0 and 7.3 could also reflect a 
dependence of the transporter on a transmembrane proton 
gradient. We have shown previously that the initial rate of 
lysosomal cysteine uptake is diminished by 60% when 
uptakes are performed at pH 7.0 in the presence of either 
15 /zM carbonyl m-chlorophenylhydrazone r 25 /zM 
monensin containing 75 mM NaCl [1]. These ionophores 
are known to dissipate the transmembrane proton gradient 
across the lysosomal membrane [20-22]. One concern in 
using ionophores is that a decrease in transport activity 
could also be due to the ionophore interacting with mem- 
The pH dependence for inactivating lysosomal cysteine 
transport by DEPC was studied by incubating lysosomes at 
30°C with 1 mM DEPC at various pH values over the 
range from pH 5 to 8. Lysosomes then were washed in an 
imidazole containing buffer at 4 ° C, and the rate of L- 
[35S]cysteine uptake at pH 7.0 and 37 ° C was measured in 
a 5 min time-course assay. The results shown in Fig. 5 
indicate that the pH dependence for DEPC inactivation of 
lysosomal cysteine uptake closely resembles the pH activ- 
ity curve for lysosomal cysteine uptake. Half-maximal 
inactivation occurs near pH 6.6 which is consistent with 
titration of the imidazole group of a histidine residue [16]. 
This close correspondence suggests that the pH activity 
curve of the cysteine-specific lysosomal transport system 
reflects titration of an essential histidine residue of the 
transport protein. 
For some enzymes in which an essential histidine residue 
has been modified with DEPC, it has been possible to 
reactivate the enzyme by exposure to hydroxylamine which 
results in decarbethoxylation f the modified histidine 
residue(s). The hydroxylamine concentration and the 
amount of time required for reactivation can vary widely 
for different proteins from 20 mM hydroxylamine for 30 
min to 750 mM hydroxylamine for 20 h [15]. To determine 
if the DEPC modified cysteine transporter could be reacti- 
vated by hydroxylamine during a short incubation period, 
lysosomes were incubated with 1 mM DEPC for 30 min at 
pH 7.3 and 30 ° C, then exposed to 50 mM hydroxylamine 
for 30 min at pH 7.3. Lysosomes then were washed by 
dilution/centrifugation a d assayed for cysteine transport 
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Fig. 5. pH dependence for inactivation of lysosomal cysteine uptake by l 
mM DEPC. Lysosomes, prepared from 12 confluent roller bottles of 
fibroblasts, were suspended in 360 /zl of 0.25 M sucrose; 30 /xl aliquots 
of the lysosomal suspension were mixed with 90 /xl of 80 mM sodium 
phosphate buffer of the indicated pH containing 1.33 mM DEPC. Incuba- 
tions were performed for 30 min at 30 ° C and then terminated by washing 
the lysosomes by dilution/centrifugation as described in Materials and 
methods. Lysosomal pellets were resuspended with 75 /xl of ice-cold 40 
mM Mops/Tris pH 7.0 buffer containing 0.25 M sucrose. The rate of 
L-[35S]cysteine uptake for each lysosomal suspension then was measured 
by incubating 50 p,1 aliquots of a given lysosomal suspension with 50 /zl 
of 40 /xM L-[35S]cysteine and performing a 5 min time-course assay as 
described in Materials and methods. In addition to the DEPC-containing 
incubations described above, control incubations were carried out in 
sodium phosphate pH 5.1 and pH 6.6 buffers in the absence of DEPC. 
The average of the untreated controls was 0.0289 + 0.0002 pmol L-cys- 
teine taken up per min per /.~g lysosomal protein. 
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Fig. 6. Cysteine uptake by lysosomal membrane vesicles in the presence 
or absence of a proton gradient. Lysosomal membrane vesicles were 
prepared by hypotonic lysis of isolated lysosomes in either 20 mM 
Mops/Tris pH 7.4 buffer or 20 mM Mes/Tris pH 5.3 buffer containing 
protease inhibitors as described in Materials and methods. Following 
centrifugation, lysosomal membrane vesicles were resuspended in 100/xl 
of the same buffer used for hypotonic lysis but without protease in- 
hibitors. Aliquots (30 /*1) of each vesicle suspension were mixed with an 
equal volume of 30 /xM L-[3-SSlcysteine prepared so that the final pH of 
the incubation mixture was pH 7.4. Incubation mixtures were placed at 
37 ° C, and at the indicated times, 9 /zl aliquots were removed, and 
applied to Sephadex G-50 columns. Material eluting in the void volume 
was mixed with 16 ml scintillation fluid and counted for radioactivity. 
brane domains affecting transport activity. Thus, an 
ionophore could cause a decrease in transport activity 
without he carrier actuality being responsive to changes in 
the transmembrane proton gradient. To assess the response 
of the cysteine-specific lysosomal transporter to an im- 
posed transmembrane prc,ton gradient in which ionophores 
are not used, we hypotonically sed Percoll-purified lyso- 
somes to form lysosomal membrane vesicles having an 
intravesicular pH of either 5.3 or 7.4. L-[35S]Cysteine 
uptake into these vesicles then was measured with the 
extravesicular pH adjusted to pH 7.4. The results shown in 
Fig. 6 demonstrate that the rate of cysteine uptake is 
~ 1.5-fold greater when pHou t7.4 > PHi, 5.3 as compared 
to uptakes performed when pHin = PHou t= 7.4. These re- 
sults provide additional evidence that part of the pH 
dependence of the cysteine-specific lysosomal transport 
system is due to a responsiveness to the lysosomal proton 
gradient which accelerates the rate of cysteine ntry into 
the lysosomal compartment. 
4. Discussion 
The cysteine-specific ilysosomal transport system is dis- 
tinct from other amino acid transport systems that recog- 
nize cysteine by displaying high specificity for cysteine 
while poorly recognizing relatively similar amino acids 
such as homocysteine, serine, alanine, and threonine [1]. 
Our previous observation that significant amounts of cys- 
teine are sequestered into the lysosomal compartment via 
this transport route and that the pH activity curve of the 
cysteine carrier is aptly designed for net delivery of cys- 
teine into lysosomes, has led us in the present investigation 
to examine what factors account for the pH dependence of
the cysteine-specific lysosomal transport system. Previ- 
ously, we provided evidence that agents which are known 
to dissipate the lysosomal transmembrane proton gradient 
result in a decrease in lysosomal cysteine uptake [1]. In the 
present study, we further substantiated this finding by 
demonstrating a greater rate of cysteine uptake into human 
fibroblast lysosomal membrane vesicles when a transmem- 
brane proton gradient was present (PHoa t 7.4 > pH i 5.3) 
than when absent (pHou t 7.4 = pH i 7.4). Thus, part of the 
pH dependence of the cysteine-specific lysosomal trans- 
port system is due to an increase in cysteine uptake in 
response to the proton gradient (pHou t> PHin) across the 
lysosomal membrane of intact lysosomes. 
Our analysis of the effects of various chemical modify- 
ing agents revealed that lysosomal cysteine transport activ- 
ity is strongly inactivated by diethyl pyrocarbonate and 
N-ethylmaleimide. The effect of NEM suggests that a thiol 
may play an important role in the operation of the lysoso- 
mal cysteine transporter. However, since the only known 
substrate for the cysteine-specific lysosomal transport sys- 
tem is a thiol, we were unable to perform substrate protec- 
tion experiments to determine if NEM inactivation in- 
volved reaction with a thiol located in the transport protein 
binding site. It may be noteworthy that lysosomal cysteine 
uptake steadily declines with increasing pH above pH 7.3 
such that only a small amount of cysteine transport is 
observed by pH 8.5 (Fig. 1). This response to pH may 
reflect deprotonation f a thiol important for the transport 
activity of the cysteine-specific lysosomal carrier or reflect 
deprotonation f the substrate, cysteine. 
Inactivation by diethyl pyrocarbonate is highly consis- 
tent with modification of a histidine residue. This finding 
is based on the pH dependence for DEPC inactivation of 
lysosomal cysteine transport which exhibits minimal inac- 
tivation at pH values less than 6, half-maximal inactivation 
at ~ pH 6.6, and maximal inactivation at pH >_ 7.3, a 
profile characteristic of DEPC reaction with histidine [16]. 
The substrate, cysteine, completely protects the transport 
protein from DEPC inactivation suggesting location of this 
essential histidine residue in the carrier's ubstrate binding 
site whereas the non-substrate, alanine, fails to protect he 
cysteine carrier from DEPC inactivation. The substrate 
protection experiments, however, do not exclude the possi- 
bility that an essential histidine could lie outside the amino 
acid binding site and upon substrate binding to the trans- 
porter, conformational changes within the carrier could 
block accessibility of the essential histidine residue to 
DEPC. 
We did not obtain any evidence for other amino acids, 
which could have titratable groups in the pH range from 
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pH 6-7.5, being required for transport activity. The car- 
boxyl-reactive agent, DCCD, and the amino reactive agent, 
PITC, had little effect on lysosomal cysteine transport. 
Overall, our results indicate that the imidazole side chain 
of the essential histidine residue must be deprotonated to
allow for transport by the cysteine-specific lysosomal 
transport protein. Consequently, the cysteine-specific lyso- 
somal transport system would not be expected to signifi- 
cantly participate in the export of cysteine from the lysoso- 
mal compartment since, at the human fibroblast intralyso- 
somal pH of 5.3, the essential histidine residue(s) would be 
protonated to a large degree. In view of the pH dependence 
of the cysteine-specific lysosomal transport system, it may 
be insightful to examine in future investigations whether 
intralysosomal thiol levels are significantly lowered upon 
alkalinization of the lysosomal interior. For instance, as the 
intralysosomal pH is raised from pH 5.3 to 6.3, the cys- 
teine-specific lysosomal transport system would be ex- 
pected to significantly contribute to the export of cysteine 
from the lysosomal compartment with the possibility of 
thereby lowering steady state intralysosornal cysteine lev- 
els. Thiol has been shown to be important for a variety of 
lysosomal hydrolytic activities [3-7], and thus substantial 
decreases in intralysosomal cysteine levels may diminish 
the activity of some lysosomal hydrolases. This possibility 
may be particularly relevant o ras transformation of hu- 
man fibroblasts which Jiang et al have shown to cause 
alkalinization of the lysosomal interior from pH 5.0 to pH 
6.l [23]. Recently, Sameni et al. [24] have shown that the 
rate of intralysosomal processing of cathepsin B is delayed 
in ras transformed human breast epithelial cells. The extent 
to which diminished lysosomal hydrolytic activity as a 
result of lysosomal alkalinization is due to a given enzy- 
matic activity operating at a sub-optimal pH or due to the 
effect of possibly lowered thiol levels remains to be deter- 
mined. 
Despite the present knowledge of approx. 20 different 
lysosomal transport systems and three different genetic 
disorders due to defects in lysosomal transport [25], neither 
a gene or a protein has been isolated for any of the 
lysosomal transport systems. Identification of amino acid 
residues essential for transport function is an important 
step in understanding the lysosomal carriers at the molecu- 
lar level. Future experiments can grow upon this base of 
knowledge and ultimately lead to the isolation and further 
molecular characterization f these proteins. The results of 
the present study, demonstrating substrate protection of the 
cysteine-specific lysosomal transport system from DEPC 
inactivation, suggest he feasibility of specifically labelling 
this transport protein with radiolabelled DEPC after modi- 
fying other lysosomal protein histidine residues with unla- 
belled DEPC in the presence of substrate. 
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